Kapadia Sandip — SEC insider filings

SEC reporting owner CIK 1677141. 30 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 30 filings on record, filed 2020-10-05 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Harmony Biosciences Holdings, Inc. (HRMY)CHIEF FINANCIAL OFFICER17—9 legs · 103,469 sh · $3,889,75437
INTERCEPT PHARMACEUTICALS, INC. (ICPT)CFO and Treasurer4—2 legs · 3,956 sh · $111,4545
Passage BIO, Inc. (PASG)Director7—1 leg · 5,000 sh · $5,9646
WINDWARD BIO GROUP AG (WWB)Director2——2

Insider filings — Kapadia Sandip

FiledFormIssuerReported transactionsSource
2026-11-164WINDWARD BIO GROUP AG (WWB)Grant/award (A): 100,000 @ $0 · Grant/award (A): 22,675 (derivative) @ $0EDGAR
2026-11-123WINDWARD BIO GROUP AG (WWB)Holdings only — no transactions reportedEDGAR
2026-05-214Passage BIO, Inc. (PASG)Grant/award (A): 10,539 (derivative) @ $0EDGAR
2026-01-284Harmony Biosciences Holdings, Inc. (HRMY)Sale (S): 3,746 @ $37.15EDGAR
2026-01-264Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 3,813 @ $0 · Tax withholding (F): 2,239 @ $36.82 · Option exercise (M): 4,725 @ $0 · Tax withholding (F): 2,553 @ $36.82 · Grant/award (A): 42,600 (derivative) @ $0 · Grant/award (A): 12,200 (derivative) @ $0 · +2 moreEDGAR
2026-01-204Harmony Biosciences Holdings, Inc. (HRMY)Sale (S): 20,961 @ $35.92EDGAR
2025-12-094Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 20,000 @ $29.03 · Sale (S): 20,000 @ $39.54 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2025-11-254Harmony Biosciences Holdings, Inc. (HRMY)Sale (S): 3,427 @ $35EDGAR
2025-10-024Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 45,000 @ $0 · Tax withholding (F): 24,039 @ $27.56 · Option exercise (M): 45,000 (derivative) @ $0EDGAR
2025-08-194Harmony Biosciences Holdings, Inc. (HRMY)Sale (S): 21,573 @ $36.50EDGAR
2025-05-304Passage BIO, Inc. (PASG)Grant/award (A): 201,857 (derivative) @ $0EDGAR
2025-04-034Harmony Biosciences Holdings, Inc. (HRMY)Sale (S): 6,247 @ $32.48 · Sale (S): 740 @ $33.12EDGAR
2025-04-014Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 15,000 @ $0 · Tax withholding (F): 8,014 @ $33.19 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-01-284Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 3,812 @ $0 · Tax withholding (F): 2,037 @ $38.01 · Sale (S): 1,775 @ $38.05 · Option exercise (M): 3,812 (derivative) @ $0 · Grant/award (A): 66,250 (derivative) @ $0 · Grant/award (A): 18,900 (derivative) @ $0EDGAR
2025-01-234Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 25,000 @ $29.03 · Sale (S): 25,000 @ $40.18 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2024-10-024Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 60,000 @ $0 · Tax withholding (F): 32,052 @ $40 · Option exercise (M): 60,000 (derivative) @ $0EDGAR
2024-05-234Passage BIO, Inc. (PASG)Grant/award (A): 47,693 (derivative) @ $0EDGAR
2024-04-024Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 15,000 @ $0 · Tax withholding (F): 8,013 @ $33.58 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2024-01-264Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 74,250 (derivative) @ $0 · Grant/award (A): 15,250 (derivative) @ $0EDGAR
2023-11-084Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2023-05-264Passage BIO, Inc. (PASG)Grant/award (A): 24,000 (derivative) @ $0EDGAR
2023-03-314Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 30,000 @ $0 · Tax withholding (F): 15,414 @ $33.36 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2022-12-024Passage BIO, Inc. (PASG)Sale (S): 5,000 @ $1.19EDGAR
2022-05-314Passage BIO, Inc. (PASG)Grant/award (A): 24,000 (derivative) @ $0EDGAR
2021-05-284Passage BIO, Inc. (PASG)Grant/award (A): 16,918 (derivative) @ $0EDGAR
2021-03-314Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 60,000 (derivative) @ $0 · Grant/award (A): 230,000 (derivative) @ $0EDGAR
2021-01-264INTERCEPT PHARMACEUTICALS, INC. (ICPT)Grant/award (A): 17,200 @ $0 · Grant/award (A): 26,900 (derivative) @ $0EDGAR
2021-01-054INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 859 @ $24.70 · Tax withholding (F): 342 @ $24.70 · Sale (S): 2,193 @ $24.47EDGAR
2020-12-164INTERCEPT PHARMACEUTICALS, INC. (ICPT)Sale (S): 1,763 @ $32.78EDGAR
2020-10-054INTERCEPT PHARMACEUTICALS, INC. (ICPT)Tax withholding (F): 296 @ $42.08EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1677141 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs